Browsing Tag
Helmy Eltoukhy
2 posts
Guardant Health launches Hereditary Cancer Test to expand precision oncology offerings
Guardant Health unveils its new hereditary cancer test to detect inherited genetic risks across 12+ cancer types. Learn how this aids precision treatment plans.
May 20, 2025
FDA approves Guardant360 CDx assay as companion diagnostic for Menarini’s ORSERDU for metastatic breast cancer
Guardant Health, an oncology company, has secured the approval of the US Food and Drug Administration (FDA) for…
February 1, 2023